LGALS9 and psoriasis: While some studies propose Gal-9 as a therapeutic target, clinical data from Nofal et al. show no significant correlation between serum Gal-9 levels and Psoriasis Area Severity Index, though associations with leukocyte/eosinophil counts and hepatic enzymes persist (66, 100).